Does FOSTAMATINIB Cause Disease progression? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Disease progression have been filed in association with FOSTAMATINIB (TAVALISSE). This represents 0.2% of all adverse event reports for FOSTAMATINIB.
12
Reports of Disease progression with FOSTAMATINIB
0.2%
of all FOSTAMATINIB reports
2
Deaths
1
Hospitalizations
How Dangerous Is Disease progression From FOSTAMATINIB?
Of the 12 reports, 2 (16.7%) resulted in death, 1 (8.3%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSTAMATINIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does FOSTAMATINIB Cause?
Diarrhoea (904)
Platelet count decreased (804)
Product dose omission issue (711)
Off label use (680)
Hospitalisation (403)
Platelet count (375)
Drug ineffective (340)
Fatigue (332)
Blood pressure increased (314)
Death (307)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which FOSTAMATINIB Alternatives Have Lower Disease progression Risk?
FOSTAMATINIB vs FOSTEMSAVIR TROMETHAMINE
FOSTAMATINIB vs FOTEMUSTINE
FOSTAMATINIB vs FRAMYCETIN
FOSTAMATINIB vs FREMANEZUMAB
FOSTAMATINIB vs FREMANEZUMAB-VFRM